2012 Research Highlight

What controls PTEN and what it controls (in prostate cancer) FREE
Paramita M Ghosh
Asian J Androl : 130-131; 10.1038/aja.2011.122
Abstract | PDF [2830]| Full Text@Pubmed Central

External-beam radiation therapy should be given with androgen deprivation treatment for intermediate-risk prostate cancer: new confirmatory evidence FREE
Matthew R Cooperberg
Asian J Androl : 132-133; 10.1038/aja.2011.136
Abstract | PDF [2940]| Full Text@Pubmed Central

Can erectile function be predicted after prostate cancer treatment? FREE
Frances M Alba¹ and Run Wang^1,2
Asian J Androl : 134-135; 10.1038/aja.2011.165
Abstract | PDF [3036]| Full Text@Pubmed Central

Health-related quality of life outcomes in Scandinavian patients after radical prostatectomy or watchful waiting: a critical appraisal FREE
Andrea A Chan¹, Steven E Canfield^1,2 and Run Wang^1,2
Asian J Androl : 136-137; 10.1038/aja.2011.162
Abstract | PDF [2843]

Altered histone retention and epigenetic modifications in the sperm of infertile men FREE
Rafael Oliva and Josep Luís Ballescà
Asian J Androl : 239-240; 10.1038/aja.2011.159
Abstract | PDF [3078]| Full Text@Pubmed Central

Another road leads to HIF-1 activation: implications for prostate cancer progression FREE
Yao Dai¹, Kyungmi Bae² and Dietmar W Siemann¹
Asian J Androl : 241-242; 10.1038/aja.2011.163
Abstract | PDF [3199]| Full Text@Pubmed Central

Heart healthy=prostate healthy: SELECT, the symbolic end of preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms? FREE
Mark A Moyad
Asian J Androl : 243-244; 10.1038/aja.2011.174
Abstract | PDF [2833]| Full Text@Pubmed Central

The importance of combined radiation and endocrine therapy in locally advanced prostate cancer FREE
Phillip J Gray^1,2 and William U Shipley²
Asian J Androl : 245-246; 10.1038/aja.2011.177
Abstract | PDF [2929]| Full Text@Pubmed Central

High-risk prostate cancer: is androgen deprivation monotherapy still appropriate? FREE
Vahakn B Shahinian
Asian J Androl : 419-420; 10.1038/aja.2011.182
Abstract | PDF [2888]| Full Text@Pubmed Central

Dietary fats may impact semen quantity and quality FREE
Jørn Olsen and Cecilia Høst Ramlau-Hansen
Asian J Androl : 511-512; 10.1038/aja.2012.52
Abstract | PDF [2215]| Full Text@Pubmed Central

Pum 1 sequesters apoptosis during spermatogenesis FREE
W Steven Ward
Asian J Androl : 513-513; 10.1038/aja.2012.35
Abstract | PDF [2121]| Full Text@Pubmed Central

The roles of omega-3 and omega-6 fatty acids in idiopathic male infertility FREE
Mohammad Reza Safarinejad and Shiva Safarinejad
Asian J Androl : 514-515; 10.1038/aja.2012.46
Abstract | PDF [2339]| Full Text@Pubmed Central

Derivation of male germ cells from induced pluripotent stem (iPS) cells: a novel and crucial source for generating male gametes FREE
Zuping He
Asian J Androl : 516-517; 10.1038/aja.2012.44
Abstract | PDF [2312]| Full Text@Pubmed Central

COX-2 inhibitors in prostate cancer treatment--hold your horses? FREE
Ada S Cheung and Mathis Grossmann
Asian J Androl : 518-519; 10.1038/aja.2012.51
Abstract | PDF [2461]| Full Text@Pubmed Central

Combining active immunotherapy with immune checkpoint blockade for the treatment of advanced prostate cancer FREE
Emmanuel S Antonarakis
Asian J Androl : 520-521; 10.1038/aja.2012.45
Abstract | PDF [2398]| Full Text@Pubmed Central

Prostate cancer stem cells: molecular characterization for targeted therapy FREE
Asfar S Azmi¹ and Fazlul H Sarkar^1,2
Asian J Androl : 659-660; 10.1038/aja.2012.62
Abstract | PDF [2165]| Full Text@Pubmed Central

Circumcision reduces prostate cancer risk FREE
Brian J Morris¹ and Jake H Waskett²
Asian J Androl : 661-662; 10.1038/aja.2012.47
Abstract | PDF [2288]| Full Text@Pubmed Central

PSA-negative/low prostate cancer cells: the true villains of CRPC? FREE
David J Mulholland
Asian J Androl : 663-664; 10.1038/aja.2012.69
Abstract | PDF [2318]| Full Text@Pubmed Central

Telomerase turns telomere dysfunction from bad to worse FREE
Sahn-Ho Kim, Evelyn R Barrack and G Prem Veer Reddy
Asian J Androl : 665-666; 10.1038/aja.2012.37
Abstract | PDF [2299]| Full Text@Pubmed Central

Testosterone therapy and mortality in US veterans FREE
Bu B Yeap^1,2
Asian J Androl : 667-668; 10.1038/aja.2012.74
Abstract | PDF [2322]| Full Text@Pubmed Central

Pumilio 1 control of spermatogenesis: a roadmap for future research FREE
Gabor Huszar
Asian J Androl : 669-660; 10.1038/aja.2012.38
Abstract | PDF [2078]| Full Text@Pubmed Central

A picture with more details is painted for prostate cancer FREE
Wennuan Liu^1,2, Junjie Feng^1,2 and Jianfeng Xu^1,2,3
Asian J Androl : 799-800; 10.1038/aja.2012.73
Abstract | PDF [2620]| Full Text@Pubmed Central

Mapping mutations in prostate cancer exomes FREE
Benjamin Sunkel^1,2 and Qianben Wang^1,2
Asian J Androl : 801-802; 10.1038/aja.2012.75
Abstract | PDF [2286]| Full Text@Pubmed Central

Implications of the prostate intervention versus observation trial (PIVOT) FREE
Oliver Sartor
Asian J Androl : 803-804; 10.1038/aja.2012.93
Abstract | PDF [2192]| Full Text@Pubmed Central

Enzalutamide (formerly MDV3100) as a new therapeutic option for men with metastatic castration-resistant prostate cancer FREE
Jeanny B Aragon-Ching
Asian J Androl : 805-806; 10.1038/aja.2012.113
Abstract | PDF [2372]| Full Text@Pubmed Central

New genetic markers for male fertility FREE
Alberto Ferlin
Asian J Androl : 807-808; 10.1038/aja.2012.84
Abstract | PDF [2237]| Full Text@Pubmed Central

Study clarifies associations between hypogonadism and health in aging men FREE
John K Amory
Asian J Androl : 809-810; 10.1038/aja.2012.78
Abstract | PDF [2218]| Full Text@Pubmed Central

DNA damage, NF-κB and accelerated aging FREE
David G Le Couteur^1,2 and David J Handelsman¹
Asian J Androl : 811-812; 10.1038/aja.2012.88
Abstract | PDF [2395]| Full Text@Pubmed Central

Long-term cross-sex hormone treatment is safe in transsexual subjects FREE
Maria Cristina Meriggiola and Marta Berra
Asian J Androl : 813-814; 10.1038/aja.2012.89
Abstract | PDF [2559]| Full Text@Pubmed Central